Literature DB >> 23834770

Midgestation fetal pulmonary annulus size is predictive of outcome in tetralogy of fallot.

Kevin Friedman1, Sowmya Balasubramanian, Wayne Tworetzky.   

Abstract

BACKGROUND: Surgical management of tetralogy of Fallot (TOF) is increasingly moving toward valve-sparing approaches rather than transannular patch (TAP). We evaluate whether fetal pulmonary valve (PV) size is predictive of postnatal course and surgical approach in TOF.
METHODS: In this retrospective study, fetal and postnatal demographic, clinical, and echocardiographic data on 66 patients diagnosed prenatally with TOF were collected. We compared those with midgestation PV z-score > -3.5 to those with z-score ≤-3.5. We analyzed fetal and postnatal PV size and growth and outcomes between groups
RESULTS: Gestational age at first fetal echo was 23 weeks (range 18-28). PV diameter and z-score on midgestation echo were 3.5 mm (1.3-6.0) and -2.8 (-0.5 to -6.0) respectively. Patients with PV z-score ≤ -3.5 on first fetal echo had smaller PV diameter (4.5 vs. 5.0 mm, P = .047) and PV z-score (-3.8 vs. -2.8, P < .001) in late gestation and at time of surgery (6.0 mm vs. 7.0 mm, P = .01; z-score = -2.9 vs. -1.7, P = .007). Similarly, those with smaller fetal PV z-score had smaller main and branch pulmonary arteries at time of surgery. PV growth rate over gestation was similar between groups, while after-birth PV growth rate was lower in those with smaller PV (0 mm/month vs. 0.6 mm/month, P = .002). Those with smaller pulmonary valve were more likely to be cyanotic (P = .05), to undergo surgery at <1 month (P < .01), and to have a TAP repair (P = .01). Among patients undergoing valve-sparing repair, those with smaller PV underwent more reinterventions for residual valvar PS (P < .01).
CONCLUSION: Midgestation fetal PV size is predictive of postnatal PV and PA size in TOF. Midgestation PV size has implications for timing and type of surgical management as well as for need for reintervention in valve-sparing repair patients and is therefore important to consider in prenatal counseling for TOF fetuses.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Congenital Heart Disease; Echocardiography; Fetal Cardiology; Tetralogy of Fallot

Mesh:

Year:  2013        PMID: 23834770      PMCID: PMC4304675          DOI: 10.1111/chd.12120

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  23 in total

Review 1.  Valve-sparing options in tetralogy of Fallot surgery.

Authors:  Emile Bacha
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2012

2.  Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair.

Authors:  A L Knauth; K Gauvreau; A J Powell; M J Landzberg; E P Walsh; J E Lock; P J del Nido; T Geva
Journal:  Heart       Date:  2006-11-29       Impact factor: 5.994

3.  Effectiveness of prenatal diagnosis of congenital heart defects in South Australia: a population analysis 1999-2003.

Authors:  Nee Scze Khoo; Phillipa Van Essen; Malcolm Richardson; Terry Robertson
Journal:  Aust N Z J Obstet Gynaecol       Date:  2008-12       Impact factor: 2.100

4.  Tetralogy of Fallot: prediction of outcome in the mid-second trimester of pregnancy.

Authors:  D Escribano; I Herraiz; Ma Granados; J Arbues; A Mendoza; A Galindo
Journal:  Prenat Diagn       Date:  2011-09-06       Impact factor: 3.050

5.  The evolving role of intraoperative balloon pulmonary valvuloplasty in valve-sparing repair of tetralogy of Fallot.

Authors:  Joshua D Robinson; Rahul H Rathod; David W Brown; Pedro J Del Nido; James E Lock; Doff B McElhinney; Emile A Bacha; Audrey C Marshall
Journal:  J Thorac Cardiovasc Surg       Date:  2011-06-24       Impact factor: 5.209

6.  Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia.

Authors:  David M Harrild; Charles I Berul; Frank Cecchin; Tal Geva; Kimberlee Gauvreau; Frank Pigula; Edward P Walsh
Journal:  Circulation       Date:  2009-01-12       Impact factor: 29.690

Review 7.  Tetralogy of Fallot.

Authors:  Christian Apitz; Gary D Webb; Andrew N Redington
Journal:  Lancet       Date:  2009-08-14       Impact factor: 79.321

8.  Outcome of pulmonary valve replacements in adults after tetralogy repair: a multi-institutional study.

Authors:  Thomas P Graham; Yvonne Bernard; Patrick Arbogast; Sravan Thapa; Frank Cetta; John Child; Reema Chugh; William Davidson; Roger Hurwitz; Joseph Kay; Stephen Sanders; Maria Schaufelberger
Journal:  Congenit Heart Dis       Date:  2008 May-Jun       Impact factor: 2.007

9.  Outcomes of prenatally diagnosed tetralogy of Fallot: Implications for valve-sparing repair versus transannular patch.

Authors:  A Hirji; A Bernasconi; B W McCrindle; E Dunn; R Gurofsky; C Manlhiot; S E Miner; J C Kingdom; E T Jaeggi; G Van Arsdell; L E Nield
Journal:  Can J Cardiol       Date:  2010-01       Impact factor: 5.223

Review 10.  Tetralogy of Fallot.

Authors:  Frederique Bailliard; Robert H Anderson
Journal:  Orphanet J Rare Dis       Date:  2009-01-13       Impact factor: 4.123

View more
  3 in total

1.  The Effects of Hemodynamic Alterations on Lung Volumes in Fetuses with Tetralogy of Fallot: An MRI Study.

Authors:  Vanessa Berger-Kulemann; Rudolf Berger; Elisabeth Mlczoch; Daniel Sternal; Mariella Mailath-Pokorny; Nilouparak Hachemian; Daniela Prayer; Michael Weber; Ulrike Salzer-Muhar
Journal:  Pediatr Cardiol       Date:  2015-04-18       Impact factor: 1.655

2.  Fetal cardiac parameters for predicting postnatal operation type of fetuses with tetralogy of Fallot.

Authors:  Suyeon Park; Hye-Sung Won; Rina Kim; Mijin Kim; Jeong Jin Yu; Chun Soo Park; Tae-Jin Yun; Yewon Jung; Usamah Al Harbi; Mi-Young Lee
Journal:  Cardiovasc Ultrasound       Date:  2022-02-21       Impact factor: 2.062

3.  Ventricular Myocardial Deformation in Fetuses With Tetralogy of Fallot: A Necessary Field of Investigation.

Authors:  Xiaoyan Song; Haiyan Cao; Liu Hong; Li Zhang; Meng Li; Jiawei Shi; Juanjuan Liu; Jing Ma; Li Cui; Yi Zhang; Yuman Li; Qing Lv; Mingxing Xie
Journal:  Front Cardiovasc Med       Date:  2021-12-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.